Prime Medicine (PRME) Earnings Date & Reports

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PRME is expected to report earnings to rise 28.57% to -36 cents per share on August 06

Prime Medicine PRME Stock Earnings Reports

Q2'26

Est.

$-0.36

Q1'26

Beat

by $0.08

Q4'25

Beat

by $0.21

Q3'25

Beat

by $0.11

Q2'25

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of -28 cents, beating the estimate of -36 cents. With 1.47M shares outstanding, the current market capitalization sits at 534.63M.

View a ticker or compare two or three

Compare

PRME

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PRME